Cargando…

Comparison of G8 and ISAR Screening Results in Geriatric Urology

Background: The G8 and ISAR scores are two different screening tools for geriatric risk factors and frailty. The aim of this study was to compare the G8 and ISAR screening results in a cohort of urogeriatric patients to help clinicians to better understand and choose between the two tests. Methods:...

Descripción completa

Detalles Bibliográficos
Autores principales: Bouzan, Jobar, Stoilkov, Boris, Nellas, Spyridon, Horstmann, Marcus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8398154/
https://www.ncbi.nlm.nih.gov/pubmed/34436219
http://dx.doi.org/10.3390/medicines8080040
_version_ 1783744770109079552
author Bouzan, Jobar
Stoilkov, Boris
Nellas, Spyridon
Horstmann, Marcus
author_facet Bouzan, Jobar
Stoilkov, Boris
Nellas, Spyridon
Horstmann, Marcus
author_sort Bouzan, Jobar
collection PubMed
description Background: The G8 and ISAR scores are two different screening tools for geriatric risk factors and frailty. The aim of this study was to compare the G8 and ISAR screening results in a cohort of urogeriatric patients to help clinicians to better understand and choose between the two tests. Methods: We retrospectively evaluated 100 patients at the age of 75 and above who were treated for different urological conditions. All routinely and prospectively underwent G8 and ISAR screening tests. A G8 score ≤ 14 and an ISAR score > 2 were considered positive. The results for the two tests were compared and correlated to clinical data. Results: The mean age of the patients was 83 y (min. 75–max. 101); 78 of the patients were male, while 22 were female; 58 of the patients were G8-positive, while 42 were G8-negative; and 24 were ISAR-positive, while 76 ISAR were negative. All the ISAR-positive patients were also G8-positive. There was a significant negative correlation between the G8 and ISAR scores (r = −0.77, p < 0.001). Both tests correlated significantly with the Charlson comorbidity index, length of stay, number of coded diagnosis, and Braden score (p < 0.05). Conclusion: Both tests are significantly correlated with each other and to clinical data related to geriatric frailty. However, the G8 score has a much higher rate of positive tests, which limits its use in daily routine, and the ISAR score is therefore preferable. For “fit” geriatric patients, however, a negative G8 score can be of great use as a confirmatory test for further decision making.
format Online
Article
Text
id pubmed-8398154
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-83981542021-08-29 Comparison of G8 and ISAR Screening Results in Geriatric Urology Bouzan, Jobar Stoilkov, Boris Nellas, Spyridon Horstmann, Marcus Medicines (Basel) Article Background: The G8 and ISAR scores are two different screening tools for geriatric risk factors and frailty. The aim of this study was to compare the G8 and ISAR screening results in a cohort of urogeriatric patients to help clinicians to better understand and choose between the two tests. Methods: We retrospectively evaluated 100 patients at the age of 75 and above who were treated for different urological conditions. All routinely and prospectively underwent G8 and ISAR screening tests. A G8 score ≤ 14 and an ISAR score > 2 were considered positive. The results for the two tests were compared and correlated to clinical data. Results: The mean age of the patients was 83 y (min. 75–max. 101); 78 of the patients were male, while 22 were female; 58 of the patients were G8-positive, while 42 were G8-negative; and 24 were ISAR-positive, while 76 ISAR were negative. All the ISAR-positive patients were also G8-positive. There was a significant negative correlation between the G8 and ISAR scores (r = −0.77, p < 0.001). Both tests correlated significantly with the Charlson comorbidity index, length of stay, number of coded diagnosis, and Braden score (p < 0.05). Conclusion: Both tests are significantly correlated with each other and to clinical data related to geriatric frailty. However, the G8 score has a much higher rate of positive tests, which limits its use in daily routine, and the ISAR score is therefore preferable. For “fit” geriatric patients, however, a negative G8 score can be of great use as a confirmatory test for further decision making. MDPI 2021-07-22 /pmc/articles/PMC8398154/ /pubmed/34436219 http://dx.doi.org/10.3390/medicines8080040 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Bouzan, Jobar
Stoilkov, Boris
Nellas, Spyridon
Horstmann, Marcus
Comparison of G8 and ISAR Screening Results in Geriatric Urology
title Comparison of G8 and ISAR Screening Results in Geriatric Urology
title_full Comparison of G8 and ISAR Screening Results in Geriatric Urology
title_fullStr Comparison of G8 and ISAR Screening Results in Geriatric Urology
title_full_unstemmed Comparison of G8 and ISAR Screening Results in Geriatric Urology
title_short Comparison of G8 and ISAR Screening Results in Geriatric Urology
title_sort comparison of g8 and isar screening results in geriatric urology
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8398154/
https://www.ncbi.nlm.nih.gov/pubmed/34436219
http://dx.doi.org/10.3390/medicines8080040
work_keys_str_mv AT bouzanjobar comparisonofg8andisarscreeningresultsingeriatricurology
AT stoilkovboris comparisonofg8andisarscreeningresultsingeriatricurology
AT nellasspyridon comparisonofg8andisarscreeningresultsingeriatricurology
AT horstmannmarcus comparisonofg8andisarscreeningresultsingeriatricurology